Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lunit

Request full access

AI-powered medical solutions for cancer diagnostics and therapeutics

Seoul, South KoreaFounded 2013Biotech & Life Sciences

About Lunit

Lunit.io is a groundbreaking startup that operates in the healthcare technology sector, specifically focusing on the application of artificial intelligence (AI) in cancer detection and treatment. The company's primary mission is to increase the survival rate of cancer patients by enabling early-stage detection and accurately predicting treatment response.

Lunit.io's AI technology serves a broad range of clients, including hospitals, research institutions, and healthcare providers. A notable example is Inje University Paik Hospital, which has introduced Lunit's AI nationwide. The company's business model revolves around providing AI solutions that can be integrated into existing healthcare systems to enhance their diagnostic and treatment capabilities.

The company generates revenue by selling its AI solutions to healthcare providers. These solutions help in detecting early-stage cancers, which allows for timely management and increases the chances of survival. Additionally, by accurately predicting treatment response, Lunit's AI helps in increasing the efficacy of immunotherapy, a type of cancer treatment that uses the body's immune system to fight cancer.

Lunit.io has been recognized for its innovative approach, ranking first place in the CAMELYON Grand Challenge 2017, a competition focused on AI applications in healthcare. The company also boasts a strong network of global research and business partners, including prominent figures like Kyung Hyun Cho, Interim Deputy Director at the Center for Data Science New York University, and Helmy Eltoukhy, CEO of Guardant Health.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2022

Lunit in the Seoul ecosystem

Live from Dealroom

The Lunit office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A5 investors entered at this stage

Series B and later10 investors entered at this stage

  • Shinhan Invest
  • Legend Capital
  • Shinhan Investment Corporation
  • IMM Investment
  • Guardant Health
  • Casdin Capital
  • NSG Ventures
  • Tybourne Capital Management
  • HealthQuest Capital
  • BrightEdge
Employees mapped 334 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$24M

137 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Lunit on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.